Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026
The Middle East & Africa Animal Healthcare Market is expected to grow due to rising zoonotic diseases and increased mergers, with a projected CAGR of 5.2% till 2027.
Middle East & Africa Animal Healthcare Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Middle East & Africa Animal Healthcare Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Request for Sample Copy of Report at – https://www.coherentmarketinsights.com/insight/request-sample/3019
Good animal health is essential for efficient use of natural resources, high productivity of proteins such as meat and milk, increased consumer trust and food security in the livestock sector, and protection of farmers and consumers from food borne and other zoonotic viral pathogens. The most common zoonotic viral diseases diagnosed in the Middle East & Africa region over the past few years include rabies, dengue fever virus, Rift Valley fever, influenza virus, West Nile fever, Middle East respiratory syndrome, Alkhurma hemorrhagic fever, Crimean-Congo haemorrhagic fever, and others. Rabies virus is considered an endemic viral infectious disease in animals in Saudi Arabia. Recent scientific data indicated that incidence of rabies is increasing in camels, one of the most important animals in Saudi Arabia. According to the World Health Organization (WHO) statistics published in 2018, over ten thousands of deaths are caused annually by rabies virus in parts of Africa and Asia Pacific.
The Middle East & Africa animal healthcare market is estimated to be valued at US$ 3,883.0 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).
Increasing incidence of zoonotic viral pathogens is expected to propel the market growth during the forecast period
Increasing incidence and prevalence of zoonotic viral diseases in the region, as zoonotic diseases can easily be transmitted to humans working in close proximity with animals, is expected to drive growth of the Middle East & Africa animal healthcare market during the forecast period. According an article published in the National Center for Biotechnology Information, in August 2019, around 21,476 human deaths in Africa occur due to dog-mediated rabies every year.
Major Key Players are: Zoetis Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva, Bayer AG, Evonik Industries AG, and Archer Daniels Midland Company.
Intent of the Middle East & Africa Animal Healthcare Market Research Study:
Purchase this Premium Report (Flat USD 2000 OFF) – https://www.coherentmarketinsights.com/promo/buynow/3019
Reasons to Purchase this Report
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Middle East & Africa Animal Healthcare Market Continues to Witness Increasing Mergers and Acquisitions till 2027 appeared first on Gatorledger.
The article discusses the growth and trends in the Middle East & Africa Animal Healthcare Market, focusing on mergers and zoonotic diseases.
The increasing incidence of zoonotic diseases and strategic mergers and acquisitions are key drivers of market growth.
Major players include Zoetis Inc., Elanco, Merck & Co., Inc., and Boehringer Ingelheim GmbH.
Explore more articles in the Research Reports category
